Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Were the terms diclosed to Dutton hence the low share target?
Reply New Message
Back To Forum List View

Were the terms diclosed to Dutton hence the low share target?

posted on Apr 15, 2008 01:16PM

I know I don't know what the facts are on the settlement amounts !

I AM GLAD FOR THE SHARE BUY BACK! THEY ARE REALLY LOOKING OUT FOR US INVESTORS.

1 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply